1 2 3 4 5

The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment – a...

Höfer, Peter; Schosser, Alexandra; Calati, Raffaella; More

International Clinical Psychopharmacology . 31(1):1-7, January 2016.

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder

Kocabas, Neslihan Aygun; Antonijevic, Irina; Faghel, Carole; More

International Clinical Psychopharmacology . 26(1):1-10, January 2011.

Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of ‘subsyndromal’ anxiety disorder: a randomized, double-blind, placebo controlled trial

Kasper, Siegfried; Gastpar, Markus; Müller, Walter E.; More

International Clinical Psychopharmacology . 25(5):277-287, September 2010.

Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study

Mendlewicz, Julien; Massat, Isabelle; Linotte, Sylvie; More

International Clinical Psychopharmacology . 25(5):297-301, September 2010.

Better tolerability of St. John's wort extract WS 5570 compared to treatment with SSRIs: a reanalysis of data from controlled clinical trials in acute major depression

Kasper, Siegfried; Gastpar, Markus; Möller, Hans-Juergen; More

International Clinical Psychopharmacology . 25(4):204-213, July 2010.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study

Kocabas, Neslihan Aygun; Faghel, Carole; Barreto, Mara; More

International Clinical Psychopharmacology . 25(4):218-227, July 2010.

5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder

Noro, Magali; Antonijevic, Irina; Forray, Carlos; More

International Clinical Psychopharmacology . 25(4):228-231, July 2010.

Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients

Serretti, Alessandro; Calati, Raffaella; Massat, Isabelle; More

International Clinical Psychopharmacology . 24(5):250-256, September 2009.

Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram

Kasper, Siegfried; Sacher, Julia; Klein, Nikolas; More

International Clinical Psychopharmacology . 24(3):119-125, May 2009.

Which antidepressants have demonstrated superior efficacy? A review of the evidence

Montgomery, Stuart A.; Baldwin, David S.; Blier, Pierre; More

International Clinical Psychopharmacology . 22(6):323-329, November 2007.

1 2 3 4 5